IMPROVED IRON CHELATION WITH DEFERASIROX AND ZINC COMBINATIONAL THREAPY IN PATIENTS WITH BETA THALASSEMIA MAJOR: IS IT ADDITIVE OR SYNERGISTIC?

被引:0
|
作者
Unal, S. [1 ]
Celik, T. [2 ]
Ozer, C. [2 ]
Ilhan, G. [1 ]
Oktay, G. [1 ]
机构
[1] Antakya State Hosp, Antakya, Turkey
[2] Mustafa Kemal Univ, Antakya, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0930
引用
收藏
页码:385 / 385
页数:1
相关论文
共 50 条
  • [31] IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR
    OLIVIERI, NF
    BRITTENHAM, GM
    MATSUI, D
    BERKOVITCH, M
    BLENDIS, LM
    CAMERON, RG
    MCCLELLAND, RA
    LIU, PP
    TEMPLETON, DM
    KOREN, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14): : 918 - 922
  • [32] Immunological Evialuation of β-Thalassemia Major Patients Receiving Oral Iron Chelator Deferasirox
    Aleem, Aamer
    Shakoor, Zahid
    Alsaleh, Khalid
    Algahtani, Farjah
    Iqbal, Zafar
    Al-Momen, Abdulkareem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (07): : 467 - 471
  • [33] Iron-chelation therapy with oral chelators in patients with thalassemia major
    Uygun, Vedat
    Kurtoglu, Erdal
    HEMATOLOGY, 2013, 18 (01) : 50 - 55
  • [34] DEFERASIROX AND ISOLATED JAUNDICE: A NEW SIDE EFFECT OF ORAL IRON CHELATION THERAPY FOR DELTA-BETA THALASSEMIA
    Cecere, F.
    Gallo, V.
    Pollio, G.
    De Anseris, A. G.
    De Matteo, A.
    Albano, R.
    HAEMATOLOGICA, 2017, 102 : 155 - 156
  • [35] Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major
    Sultan, Sadia
    Irfan, Syed Mohammed
    Kakar, Jamaluddin
    Zeeshan, Rozina
    MALAYSIAN JOURNAL OF PATHOLOGY, 2015, 37 (01) : 35 - 38
  • [36] BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX
    Casale, M.
    Citarella, S.
    Amendola, G.
    Iolascon, G.
    Costantini, S.
    De Michele, E.
    Pugliese, U.
    Tartaglione, I.
    Gallicola, F.
    Cinque, P.
    Filosa, A.
    Perrotta, S.
    HAEMATOLOGICA, 2014, 99 : 442 - 443
  • [37] Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
    Eziefula, Chinea
    Shah, Farrukh
    Anie, Kofi A.
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 1423 - 1437
  • [38] Hypoparathyroidism in children with beta-thalassemia major and its relation to iron chelation therapy
    El-Din, Lerine Bahy
    Ebeid, Fatma S. E.
    Toaima, Nadin N.
    Ibrahim, Walaa W.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (02): : 63 - 68
  • [39] A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets
    Yadav, Piyush Kumar
    Singh, Ajay Kumar
    PLASMATOLOGY, 2022, 16
  • [40] A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets
    Yadav, Piyush Kumar
    Singh, Ajay Kumar
    PLASMATOLOGY, 2022, 16